An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus
Journal of Virology · 21.04.2026 · 100 (4)
DOI: 10.1128/jvi.00178-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 21.04.2026. Verfasst von Jun Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin…. Hauptthemen laut MEDLINE: Clostridium perfringens, Rotavirus Infections, Clostridium Infections, Rotavirus Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The segmented genome of live-attenuated rotavirus (RV) vaccines provides an ideal platform for developing multivalent vaccines against enteric pathogens. Here, we engineered the commercial human RV vaccine strain LLR as a vector to deliver Clostridium perfringens alpha-toxin (CPA), a critical virulence factor associated with gastroenteritis. A screen of four 2A peptide sequences identified that porcine teschovirus-1 2A (P2A) preceded by an N-terminal GSG spacer enabled optimal cleavage and antigen expression. In mice, the resulting recombinant virus elicited potent systemic antibody responses against both RV and CPA following oral administration. When tested in a maternal immunization model, intramuscular immunization of cows generated high titers of neutralizing antibodies in colostrum, demonstrating its potential utility for passive immunization. By integrating a key bacterial antigen into a licensed RV vaccine backbone, we establish a versatile strategy to combat viral-bacterial co-infections and polymicrobial enteric diseases, offering a promising new approach to reduce the global burden of diarrheal mortality. IMPORTANCE The lack of vaccines targeting polymicrobial enteric infections represents a critical gap in the fight against diarrheal diseases, a leading cause of infant mortality worldwide. To bridge this gap, we engineered a novel bivalent vaccine designed to provide dual protection against rotavirus and Clostridium perfringens alpha-toxin (CPA)-mediated disease. Leveraging an enhanced reverse genetics system, we successfully utilized the commercialized rotavirus vaccine strain LLR as a viral vector to express the key C. perfringens virulence factor, CPA. This strategy not only offers a path to broader protection against diarrheal disease but also establishes a versatile platform for developing vaccines against other viral-bacterial co-infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
- College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, People's Republic of China.
- Institute of Western Agriculture, Chinese Academy of Agricultural Sciences, Changji, China.
ORCID-Profile: Jun Wang, Jitao Chang, Xin Yin, Dongbo Sun
Zitieren
APA
Wang, J., Chang, J., Jiang, Z., Deng, H., Jia, Q., Li, K., Zhao, J., Xiang, H., Yang, F., Qin, S., Han, Y., Yao, B., Wang, F., Yin, X., & Sun, D. (2026). An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus. Journal of Virology, 100(4). https://doi.org/10.1128/jvi.00178-26
Vancouver
Wang J, Chang J, Jiang Z, Deng H, Jia Q, Li K, et al. An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus. Journal of Virology. 2026;100(4). doi:10.1128/jvi.00178-26
BibTeX
@article{Wang2026,
author = {Wang, Jun and Chang, Jitao and Jiang, Zhigang and Deng, Hechun and Jia, Qi and Li, Kuanhao and Zhao, Jiangang and Xiang, Haoyu and Yang, Fan and Qin, Songkang and Han, Yuxin and Yao, Binxin and Wang, Fang and Yin, Xin and Sun, Dongbo},
title = {An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus},
journal = {Journal of Virology},
year = {2026},
volume = {100},
number = {4},
doi = {10.1128/jvi.00178-26}
}
EUVIMED